Clinical Trials Sponsored by Artu Biologicals

Total 1243 results

Shanghai Institute Of Biological Products

Completed

A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects

Healthy Male

China
Hualan Biological Bacterin Co. Ltd.

Completed

Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years

GCP

China
Changchun Zhuoyi Biological Co., Ltd

Completed

Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine

Rabies | Antibody

China
Shanghai Institute Of Biological Products

Unknown

A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine

H7N9 Influenza

China
BSP Biological Signal Processing Ltd.

Unknown

Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG

Myocardial Ischemia

Israel
CanSino Biologics Inc.

Recruiting

A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years

Meningococcal Meningitis

Indonesia
CanSino Biologics Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years

Herpes Zoster

Canada
CanSino Biologics Inc.

Recruiting

Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)

Epidemic Meningitis

China
FBD Biologics Limited

Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Advanced Solid Tumor | Refractory Non-Hodgkin Lymphoma

Taiwan, United States
Polpharma Biologics S.A.

Not yet recruiting

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® (UCESIVE)

Ulcerative Colitis
Forge Biologics, Inc

Recruiting

Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT (REKLAIM)

Krabbe Disease

United States
Theriva Biologics SL

Recruiting

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer (VIRAGE)

Pancreatic Adenocarcinoma | Metastatic

Spain, United States
Direct Biologics, LLC

Recruiting

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

Acute Respiratory Distress Syndrome | ARDS

United States
TaiMed Biologics Inc.

Recruiting

TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals

HIV-1-infection

United States
Direct Biologics, LLC

Recruiting

Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease

Inflammatory Bowel Diseases | Crohn Disease

United States
ADMA Biologics, Inc.

Recruiting

An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Primary Immune Deficiency

United States
Precision Biologics, Inc

Recruiting

Study of NEO-201 in Solid Tumors Expansion Cohorts

Cervical Cancer | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Uterine Cancer

United States
Aziyo Biologics, Inc.

Completed

A Retrospective Breast Reconstruction Study

Breast Cancer

United States
CanSino Biologics Inc.

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Tetanus

China
CanSino Biologics Inc.

Active, not recruiting

Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

COVID-19

China
Aziyo Biologics, Inc.

Completed

Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix) (RECON)

Coronary Disease

United States
Aziyo Biologics, Inc.

Completed

A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope (SECURE)

Cardiovascular Disease

United States
ACR Biologics, LLC

Terminated

Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds

Pressure Ulcer | Skin Ulcer Venous Stasis Chronic | Foot Ulcer Chronic

United States
AGC Biologics S.p.A.

Completed

A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors

Advanced Solid Tumors

Italy
ADMA Biologics, Inc.

Terminated

Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

Transplantation Infection | Evidence of Liver Transplantation | Sequelae of Viral Hepatitis

United States
Aziyo Biologics, Inc.

Completed

ViBone in Cervical and Lumbar Spine Fusion

Degenerative Disc Disease | Cervical Spondylosis | Spondylosis | Spondylolisthesis | Herniated Nucleus Pulposus

United States
Markman Biologics Corporation

Unknown

Microsurfaced Grafts in Deep Burn Wounds

Burns | Wound Heal

United States
Turnstone Biologics, Corp.

Completed

Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients

Non-Small Cell Lung Cancer

Canada
TaiMed Biologics Inc.

Terminated

Study of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative Volunteers

Human Immunodeficiency Virus

United States
Precision Biologics, Inc

Terminated

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Pancreatic Cancer, Adult

United States
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma (NGR007)

Small Cell Lung Cancer

Italy
AGC Biologics S.p.A.

Completed

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Malignant Pleural Mesothelioma

United States, Spain, United Kingdom, Ireland, Italy, Belgium, Egypt, Canada, France, Netherlands, Poland, Sweden
NeXtGen Biologics, Inc.

Completed

Human Repeated Insult Patch Test

Allergy | Dermatitis | Contact Allergy

United States
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)

Colorectal Cancer (CRC)

Italy
AGC Biologics S.p.A.

Completed

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM (NGR019)

Advanced Malignant Pleural Mesothelioma

Italy, Germany, Russian Federation
AGC Biologics S.p.A.

Completed

NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)

Ovarian Cancer

Italy
LimmaTech Biologics AG

Completed

Phase I to Test a New Pneumococcal Vaccine

Pneumonia, Bacterial | Pneumococcal Pneumonia

Germany
NanoFUSE Biologics, LLC

Unknown

Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix

Bone; Degeneration
Synthetic Biologics Inc.

Completed

A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C

Irritable Bowel Syndrome With Constipation (IBS-C)

United States
Synthetic Biologics Inc.

Completed

A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI

Clostridium Infections | Clostridium Difficile

United States, Bulgaria, Canada, Hungary, Poland, Romania, Serbia
NanoFUSE Biologics, LLC

Unknown

NanoFUSE® PL Gutter PMCF

Degenerative Disc Disease
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer

Ovarian Cancer Metastatic Recurrent

Italy
AGC Biologics S.p.A.

Completed

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer (NGR018)

Ovarian Cancer

Italy, United Kingdom
AGC Biologics S.p.A.

Completed

NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Italy
AGC Biologics S.p.A.

Completed

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.

Metastatic Adult Soft Tissue Sarcoma

France, Italy, United Kingdom
Qu Biologics Inc.

Completed

Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Canada
Qu Biologics Inc.

Completed

Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Canada
Critical Biologics Corporation

Completed

Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels

Burns | Trauma | Infection | Low Gelsolin

Hong Kong
Changchun Zhuoyi Biological Co., Ltd

Completed

Vaccine Prevention of Rabies Adopts 4-shot Immunization Method

Rabies Human | Antibody Titer

China
Shanghai Institute Of Biological Products

Completed

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

Herpes Zoster

China

3

Subscribe